Cyclo Therapeutics Inc (CYTH)

Apr 29, 2025

Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™ - The Manila Times

Apr 29, 2025

Apr 29, 2025

Rafael Holdings Secures Future: $25M Rights Offering Powers Critical Phase 3 Drug Launch Plans - Stock Titan

Apr 29, 2025

Apr 26, 2025

Cyclo Therapeutics (NASDAQ:CYTH) and Genfit (NASDAQ:GNFT) Financial Comparison - Defense World

Apr 26, 2025

Apr 24, 2025

Rafael Holdings Strengthens its Focus on the Development of Trappsol Cyclo and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role - marketscreener.com

Apr 24, 2025

Apr 24, 2025

Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role - The Manila Times

Apr 24, 2025

Apr 24, 2025

Rafael Holdings Announces Leadership Transition Following Merger with Cyclo Therapeutics and Full Enrollment of TransportNPC™ Phase 3 Trial for Niemann-Pick Disease Treatment - Nasdaq

Apr 24, 2025

Apr 24, 2025

Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces - Bluefield Daily Telegraph

Apr 24, 2025

Apr 24, 2025

Rafael Holdings Pivots to Breakthrough Rare Disease Drug Development as Leadership Changes - Stock Titan

Apr 24, 2025

Apr 03, 2025

Contrasting BioNTech (NASDAQ:BNTX) and Cyclo Therapeutics (NASDAQ:CYTH) - Defense World

Apr 03, 2025

Mar 26, 2025

Rafael Holdings finalizes merger with Cyclo Therapeutics By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Rafael Closes Merger With Cyclo Therapeutics - MarketScreener

Mar 26, 2025

Mar 26, 2025

Rafael Holdings and Cyclo Therapeutics Merge - citybiz

Mar 26, 2025

Mar 26, 2025

Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals - MarketScreener

Mar 26, 2025

Mar 26, 2025

Cyclo Therapeutics Merges with Rafael Holdings - TipRanks

Mar 26, 2025

Mar 26, 2025

Rafael Holdings Completes Merger with Cyclo Therapeutics - TipRanks

Mar 26, 2025

Mar 26, 2025

Rafael Holdings finalizes merger with Cyclo Therapeutics - Investing.com

Mar 26, 2025

Mar 26, 2025

Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals - GlobeNewswire

Mar 26, 2025

Mar 26, 2025

Major Pharma Merger: Rafael Holdings Gains Phase 3 Rare Disease Asset in Strategic Deal - Stock Titan

Mar 26, 2025

Mar 25, 2025

Rafael Holdings secures shareholder nod for Cyclo Therapeutics merger By Investing.com - Investing.com Canada

Mar 25, 2025

Mar 25, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Mar 25, 2025

Mar 25, 2025

Rafael Holdings secures shareholder nod for Cyclo Therapeutics merger - Investing.com

Mar 25, 2025

Mar 24, 2025

Cyclo Therapeutics shareholders approve merger with Rafael Holdings By Investing.com - Investing.com South Africa

Mar 24, 2025

Mar 24, 2025

Cyclo Therapeutics shareholders approve merger with Rafael Holdings - Investing.com

Mar 24, 2025

Mar 23, 2025

WILLIAM SHANAHAN Obituary (2025)New York, NYNew York Times - Legacy.com

Mar 23, 2025

Mar 20, 2025

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Mar 20, 2025

Mar 20, 2025

March Madness: Flutter Stock Is a Solid Bet on Sustained Growth - The Globe and Mail

Mar 20, 2025

Mar 20, 2025

Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office - Business Wire

Mar 20, 2025

Mar 18, 2025

Q4 Earnings Highlights: Apogee (NASDAQ:APOG) Vs The Rest Of The Commercial Building Products Stocks - The Globe and Mail

Mar 18, 2025

Mar 17, 2025

Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL) - Business Wire

Mar 17, 2025

Mar 15, 2025

CYCLO THERAPEUTICS Earnings Preview: Recent $CYTH Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 15, 2025

Mar 14, 2025

Rafael Holdings Inc Reports Q2 2025 Earnings: EPS at -$0.19, Str - GuruFocus.com

Mar 14, 2025

Mar 14, 2025

Rafael Holdings, Inc. SEC 10-Q Report - TradingView

Mar 14, 2025

Mar 13, 2025

Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results - The Manila Times

Mar 13, 2025

Mar 13, 2025

Rafael Holdings, Inc. Reports Financial Results and Anticipates Closure of Merger with Cyclo Therapeutics in Q3 - Nasdaq

Mar 13, 2025

Mar 13, 2025

Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results - GlobeNewswire Inc.

Mar 13, 2025

Mar 10, 2025

Cyclo Therapeutics (CYTH) to Release Quarterly Earnings on Monday - Defense World

Mar 10, 2025

Mar 07, 2025

Cyclo Therapeutics secures $2.5 million in funding By Investing.com - Investing.com Australia

Mar 07, 2025

Mar 07, 2025

Is Cyclo Therapeutics, Inc. (CYTH) the Best Micro Cap Stock to Buy Now? - Insider Monkey

Mar 07, 2025

Mar 06, 2025

10 Best Micro Cap Stocks to Buy Now - Insider Monkey

Mar 06, 2025

Mar 06, 2025

Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings - Marketscreener.com

Mar 06, 2025

Mar 06, 2025

Cyclo Therapeutics secures $2.5 million in funding - Investing.com India

Mar 06, 2025

Feb 28, 2025

Emerging Market ETFs: A Shield Against Trump’s Tariff Threats? - The Globe and Mail

Feb 28, 2025

Feb 21, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders - The Malaysian Reserve

Feb 21, 2025

Feb 20, 2025

CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc.CYTH - Business Wire

Feb 20, 2025

Feb 20, 2025

Emera Inc (EMA:CA) Stock Analysis: Q4 2024 Earnings & Forecast - The Globe and Mail

Feb 20, 2025

Feb 15, 2025

Cyclo Therapeutics extends merger agreement with Rafael Holdings - MSN

Feb 15, 2025